Welcome to our dedicated page for LogicMark SEC filings (Ticker: LGMK), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
LogicMark, Inc.'s SEC filings document a Nevada public company focused on personal emergency response systems, health communications devices and connected-care technology. Recent Form 8-K reports furnish quarterly and fiscal-year financial results, operating highlights, investor webcast materials and general corporate developments tied to the company’s product and channel updates.
The filings also record capital-structure and governance actions, including amendments to articles of incorporation, a completed reverse stock split, withdrawals of Series H and Series I preferred stock designations, shareholder meeting timing, director-nomination procedures and annual proxy matters such as board elections and auditor ratification.
LogicMark (LGMK) filed a Form 4 disclosing a director option grant. Director John Pettitt was awarded 3,125,000 stock options on October 9, 2025 at an exercise price of $0.0032 per share. The options are listed as exercisable on October 9, 2025 and expire on October 8, 2035. Following the grant, Pettitt beneficially owns 3,125,000 derivative securities, held directly.
According to the footnote, the options were granted as compensation for service on the board for the quarter ended September 30, 2025.
LogicMark (LGMK) reported a director equity grant. On 10/09/2025, director Robert A. Curtis was awarded options to purchase 3,125,000 shares of common stock at an exercise price of $0.0032 per share. The options are listed as exercisable on 10/09/2025 and expire on 10/08/2035. Following the transaction, 3,125,000 derivative securities were beneficially owned, held directly. The filing states the options were received as compensation for board service for the quarter ended September 30, 2025.
LogicMark (LGMK) reported an insider equity award. A company director received options to purchase 3,125,000 shares of common stock on 10/09/2025 at an exercise price of $0.0032 per share (Transaction Code: A).
The options are exercisable from 10/09/2025 and expire on 10/08/2035. Following the grant, the reporting person beneficially owns 3,125,000 derivative securities, held directly. The filing notes the options were received as compensation for board service for the quarter ended September 30, 2025.
LogicMark, Inc. (LGMK) reported a director equity grant on a Form 4. On 10/09/2025, a board member received options to purchase 3,125,000 shares of common stock at an exercise price of $0.0032 per share. The options are exercisable on 10/09/2025 and expire on 10/08/2035.
The filing states the options were granted as compensation for services as a member of the board of directors for the quarter ended September 30, 2025. Following the reported transaction, the reporting person beneficially owns 3,125,000 derivative securities, held directly.